iDEL Therapeutics GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
iDEL Therapeutics GmbH - overview
Established
2025
Location
Dortmund, -, Germany
Primary Industry
Biotechnology
About
Founded in 2025 and based in Dortmund, Germany, iDEL Therapeutics GmbH operates as a biotechnology company that provides a synthetic shuttle drug delivery platform to transport therapeutic payloads directly into the cytosol of tumor cells.
Current Investors
BioMed Partners, Khanu Management, NRW.Venture
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment
Website
www.idel-tx.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.